Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors.

Delwart E, Slikas E, Stramer SL, Kamel H, Kessler D, Krysztof D, Tobler LH, Carrick DM, Steele W, Todd D, Wright DJ, Kleinman SH, Busch MP; NHLBI-REDS-II Study Group.

J Infect Dis. 2012 Mar 15;205(6):875-85. doi: 10.1093/infdis/jir862. Epub 2012 Jan 31.

2.

Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.

Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR; SIMTI Research Group.

Transfusion. 2008 Oct;48(10):2205-13. doi: 10.1111/j.1537-2995.2008.01813.x. Epub 2008 Jul 8.

PMID:
18631163
4.

Multiple genotypes and subtypes of hepatitis B and C viruses in Belarus: similarities with Russia and western European influences.

Olinger CM, Lazouskaya NV, Eremin VF, Muller CP.

Clin Microbiol Infect. 2008 Jun;14(6):575-81. doi: 10.1111/j.1469-0691.2008.01988.x. Epub 2008 Mar 27.

6.

Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.

Prasetyo AA, Dirgahayu P, Sari Y, Hudiyono H, Kageyama S.

J Infect Dev Ctries. 2013 Jun 15;7(6):453-67. doi: 10.3855/jidc.2965.

7.

Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors.

Flichman DM, Blejer JL, Livellara BI, Re VE, Bartoli S, Bustos JA, Ansola CP, Hidalgo S, Cerda ME, Levin AE, Huenul A, Riboldi V, Treviño EM, Salamone HJ, Nuñez FA, Fernández RJ, Reybaud JF, Campos RH.

BMC Infect Dis. 2014 Apr 23;14:218. doi: 10.1186/1471-2334-14-218.

8.

Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.

Japanese Red Cross NAT Screening Research Group.

Jpn J Infect Dis. 2000 Jun;53(3):116-23. Erratum in: Jpn J Infect Dis 2000 Oct;53(5):219.

PMID:
10957709
9.

Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique.

Cunha L, Plouzeau C, Ingrand P, Gudo JP, Ingrand I, Mondlane J, Beauchant M, Agius G.

J Med Virol. 2007 Dec;79(12):1832-40.

PMID:
17935167
10.

Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing.

Murokawa H, Yoshikawa A, Ohnuma H, Iwata A, Katoh N, Miyamoto M, Mine H, Emura H, Tadokoro K; Japanese Red Cross NAT Screening Research Group.

Vox Sang. 2005 Jan;88(1):10-6.

PMID:
15663717
11.

Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.

Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ; German Red Cross NAT Study Group.

Transfusion. 2008 Aug;48(8):1558-66. doi: 10.1111/j.1537-2995.2008.01718.x. Epub 2008 May 6.

PMID:
18466173
13.

Comparative analysis of triplex nucleic acid test assays in United States blood donors.

Stramer SL, Krysztof DE, Brodsky JP, Fickett TA, Reynolds B, Dodd RY, Kleinman SH.

Transfusion. 2013 Oct;53(10 Pt 2):2525-37. doi: 10.1111/trf.12178. Epub 2013 Apr 3.

14.

Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.

Noubiap JJ, Joko WY, Nansseu JR, Tene UG, Siaka C.

Int J Infect Dis. 2013 Oct;17(10):e832-7. doi: 10.1016/j.ijid.2012.12.007. Epub 2013 Jan 11.

15.

[Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].

Contreras AM, Reta CB, Torres O, Celis A, Domínguez J.

Salud Publica Mex. 2011;53 Suppl 1:S13-8. Spanish.

16.

Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.

Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R.

Transfusion. 2009 Jun;49(6):1115-25. doi: 10.1111/j.1537-2995.2009.02110.x. Epub 2009 Feb 27.

PMID:
19309474
17.

Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.

Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.

Trop Gastroenterol. 2007 Jan-Mar;28(1):19-23.

PMID:
17896605
18.

Predonation screening of candidate donors and prevention of window period donations.

Lieshout-Krikke RW, Zaaijer HL, van de Laar TJ.

Transfusion. 2015 Feb;55(2):373-8. doi: 10.1111/trf.12809. Epub 2014 Aug 7.

PMID:
25130605
19.

Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors.

Makroo RN, Choudhury N, Jagannathan L, Parihar-Malhotra M, Raina V, Chaudhary RK, Marwaha N, Bhatia NK, Ganguly AK.

Indian J Med Res. 2008 Feb;127(2):140-7.

PMID:
18403791
20.

Genetic diversity of hepatitis B virus and hepatitis C virus in human immunodeficiency virus type 1-co-infected patients from Venezuela.

Jaspe RC, Sulbarán YF, Loureiro CL, Martínez N, Devesa M, Rodríguez Y, Torres JR, Rangel HR, Pujol FH.

J Med Microbiol. 2014 Aug;63(Pt 8):1099-104. doi: 10.1099/jmm.0.067496-0. Epub 2014 Jun 3.

PMID:
24895404
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk